Stage IIIB or IIIC or IIID melanoma research hub

A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Design of Investigational Agents With or Without Pembrolizumab or Pembrolizumab Alone in Participants with Melanoma (KEYMAKER-U02): Substudy 02C

This study is for people in the UK with advanced melanoma, a type of skin cancer. It's testing new ways to treat it, sometimes combined with an existing medicine called Pembrolizumab (Keytruda). The main goals are to see how safe the new treatments are and how well they work.